Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05995223
Other study ID # UNLV-2022-489
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 4, 2023
Est. completion date December 2024

Study information

Verified date November 2023
Source University of Nevada, Las Vegas
Contact Victor DY Beck, MS
Phone 702-895-3003
Email victor.beck@unlv.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to compare the rate at which oxygen uptake adapts to submaximal, moderate intensity exercise (oxygen uptake kinetics) between adults with and without Down syndrome, to determine the contribution of oxygen uptake kinetics to exercise intolerance of adults with Down syndrome. Additionally, the study will investigate the role of oxygen delivery (by the cardiovascular circuit) and oxygen utilization (in the mitochondria) on the oxygen uptake kinetics of adults with Down syndrome to identify specific areas which adults with Down syndrome could benefit from targeting during exercise training. Overall, this study aims to contribute to the knowledge on the exercise capacity of adults with Down syndrome, in order to improve the way adults with Down syndrome participate in and benefit from exercise. Participants will perform a maximal exercise test on a treadmill, and walk on a treadmill at a submaximal, moderate intensity speed and incline, during which oxygen uptake at the lungs, cardiac output, and oxygen utilization in the muscle will be measured.


Description:

Down syndrome (Ds) is the most common chromosomal disorder, affecting approximately 1 in every 800 live births in the US. In addition to a number of comorbidities, individuals with Ds have low cardiorespiratory fitness. Their low fitness cannot be explained by low levels of physical activity, lack of motivation, or lack of understanding of the test, but rather has a physiological cause. Autonomic dysfunction has been identified as one major contributor to the low cardiorespiratory fitness in individuals with Ds, but it does not fully explain the phenomenon. Cardiorespiratory fitness is determined by the capacity of the body to produce energy, which largely relies on the ability to take up, deliver, and use oxygen. This process of oxygen transport is governed by the pulmonary, cardiovascular, and muscular system, and the degree to which they work together. At the start of exercise, these three systems respond in a delayed pattern, requiring the body to compensate energy production through anaerobic means, which negatively affect one's exercise tolerance. Thus, the quicker the adaptation of these three systems (i.e. the quicker their kinetics), the better one's ability to perform and tolerate exercise. The rate of adaption of these oxygen transport system can be quantified by assessing oxygen uptake (pulmonary), cardiac output (cardiovascular), and mitochondrial oxygen utilization (muscle) kinetics, which all show a delayed, exponential increase towards steady state at the start of moderate intensity exercise. The kinetics of these three systems have never been assessed in individuals with Ds, and could provide valuable insights into their low cardiorespiratory fitness and reduced exercise tolerance. The aim of this research proposal is therefore to determine the differences in kinetics of oxygen uptake, cardiac output, and mitochondrial oxygen utilization between individuals with and without Ds to better understand the underlying physiology and potentially improve healthy by using this knowledge for exercise interventions. Overall aim: to better understand the relation between oxygen uptake kinetics and cardiorespiratory fitness in individuals with Ds. Aim 1: To compare the rate of oxygen uptake, cardiac output, and mitochondrial oxygen utilization kinetics in response to submaximal, moderate intensity exercise between adults with and without Ds. Aim 2: To determine the relation between the rate of oxygen uptake kinetics and the peak oxygen uptake of individuals with Ds. Determining how oxygen transport affects individuals with Ds during exercise could potentially give more direction into designing exercise sessions and interventions, as their oxygen transport system potentially might need more time to reach the required working level. General study design. Participants will complete two study visits, during which their cardiorespiratory capacities will be tested using two different treadmill protocols. Familiarization with all study personnel and procedures will take place before actual measurements are performed. Description data collection visits. Participants will be tested in a postprandial state (>3 h) on 2 separate days (separated by at least 48 hours, but no more than 2 weeks) and will refrain from exercise, alcohol and caffeine for at least 24 h before each study visit. During the first visit, height, weight, and circumferences will be measured. Body composition will be measured using dual energy X-ray absorptiometry (DEXA), and echocardiography will be performed to determined aortic diameter and to screen for any potential residual cardiac deficits common in individuals with Ds. Lastly, participants will perform a graded maximal treadmill exercise test to determine peak oxygen uptake (VO2peak) and to determine the submaximal exercise intensity for the second visit. The second visit will have participants walk on an intensity associated with 80% of their ventilatory threshold for six minutes while pulmonary oxygen uptake (using breath-by-breath gas exchange analysis), cardiac output (using beat-to-beat blood pressure measurement), and muscle oxygenation (using near-infrared spectroscopy (NIRS)) is measured. This bout of six minutes will be repeated four times, with 10 minutes rest in between. The four bouts will be used to average the three signals, which improves the calculation of kinetic parameters. Familiarization. Parents/care givers are involved in order to provide a supportive environment for participants and to enhance the parent/caregiver understanding of the research. Prior to study initiation, photographs and video clips of the laboratory and study equipment will be provided to help the participants become comfortable with the laboratory environment and equipment, and the informed consent information is sent to the participants and their parents/care-givers for their review. Familiarization for the participants with Down syndrome will be divided in two parts: they will practice and become accustomed with the treadmill and the equipment for the graded maximal exercise test (very start of the first visit), and they will practice and become accustomed with the procedures for the submaximal exercise protocol (start of the second visit).


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date December 2024
Est. primary completion date July 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - low active (defined as being involved in less than 30 minutes of moderately-intense physical activity per day); - diagnosis with Down syndrome trisomy 21 (Down syndrome group only); - normal thyroid function or stable thyroid function (with medications) for at least 6 months (Down syndrome group only). Exclusion Criteria: - asthma or other pulmonary disease; - severe obesity (defined as BMI >40); - uncontrolled hypertension (defined as blood pressure >130/80 mmHg); - congenital heart disease; - diabetes (defined as Hba1c of >7.5% or use of glucose lowering medication); - current smoking; - pregnancy.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Submaximal exercise protocol
Participants will complete a submaximal walking protocol on a motorized treadmill, which consists of 4 times 6 minutes of walking at a moderate intensity speed and incline while their breathing, cardiac output, and muscle oxygen use is measured, with 10 minutes rest in between each bout.

Locations

Country Name City State
United States University of Nevada, Las Vegas Las Vegas Nevada

Sponsors (1)

Lead Sponsor Collaborator
University of Nevada, Las Vegas

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Oxygen uptake kinetics The finite rate at which oxygen uptake (measured with breath-by-breath gas exchange analysis at the mouth) adapts to a (submaximal) increase in exercise intensity, primarily captured by time constant tau, which describes the time needed to reach 63% of the required, steady state oxygen uptake Through study completion, on average 4 hours
Secondary Cardiac output kinetics The finite rate at which cardiac output (calculated from beat-to-beat blood pressure waves) adapts to a (submaximal) increase in exercise intensity, primarily captured by time constant tau, which describes the time needed to reach 63% of the required, steady state cardiac output Through study completion, on average 4 hours
Secondary Muscle deoxygenation kinetics The finite rate at which muscle oxygen utilization (measured as the production of deoxyhemoglobin at the muscle) adapts to a (submaximal) increase in exercise intensity, primarily captured by time constant tau, which describes the time needed to reach 63% of the required, steady state muscle oxygen utilization Through study completion, on average 4 hours
Secondary Steady-state cardiac output Steady state cardiac output during standing rest and submaximal exercise (in L/min) Through study completion, on average 4 hours
Secondary Absolute peak oxygen uptake Peak oxygen uptake (VO2peak; expressed in L/min) Through study completion, on average 4 hours
Secondary Relative peak oxygen uptake (corrected for total body mass) Peak oxygen uptake (VO2peak; expressed in ml/kg/min) Through study completion, on average 4 hours
Secondary Relative peak oxygen uptake (corrected for lean body mass) Peak oxygen uptake (VO2peak; expressed in L=mL/kg lean body mass/min) Through study completion, on average 4 hours
Secondary Ventilatory threshold (L/min) The threshold where ventilation starts to increase at a faster rate than oxygen uptake during a graded maximal exercise test (expressed in L/min) Through study completion, on average 4 hours
Secondary Ventilatory threshold (%VO2peak) The threshold where ventilation starts to increase at a faster rate than oxygen uptake during a graded maximal exercise test (expressed as a percentage of VO2peak) Through study completion, on average 4 hours
Secondary Stroke volume Stroke volume (mL) Through study completion, on average 4 hours
Secondary Heart rate Heart rate (in bpm) Through study completion, on average 4 hours
Secondary Oxygen uptake efficiency slope The slope between oxygen uptake (L/min) and the common logarithm of minute ventilation (L/min) during a graded maximal exercise test Through study completion, on average 4 hours
Secondary Ve/VCO2 slope The slope between minute ventilation (Ve; L/min) and carbon dioxide production (VCO2; L/min) during a graded maximal exercise test Through study completion, on average 4 hours
Secondary Lean body mass Lean body mass determined with Dual Energy X-ray Absorptiometry (DXA) scan in kg Through study completion, on average 4 hours
See also
  Status Clinical Trial Phase
Recruiting NCT04854122 - Blood Flow Regulation in Individuals With Down Syndrome - Training Study N/A
Completed NCT04020302 - Self-Monitoring Shopping Intervention N/A
Recruiting NCT01950624 - DS-Connect {TM}: The Down Syndrome Registry
Completed NCT04751136 - the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome Phase 2
Completed NCT04767412 - Inspiratory Muscle Training and Physical Fitness in Children With Down Syndrome Randomized Control Trial N/A
Completed NCT04536506 - Bobath and Vojta Therapy for DS N/A
Not yet recruiting NCT04037579 - Protocol for a Non-randomized Survey in Down Syndrome People Who Practice Sports. Self and Observers´ Perception.
Completed NCT02882698 - Performance Analysis in Down Syndrome on Mobile Phone N/A
Completed NCT01791725 - A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia Phase 2
Unknown status NCT01975545 - Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21 Phase 2
Completed NCT01808508 - Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome N/A
Terminated NCT00754052 - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17 Phase 3
Terminated NCT00754013 - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10 Phase 3
Completed NCT01313325 - Hippotherapy to Improve the Balance of Children With Movement Disorders N/A
Completed NCT01256112 - Parent Supported Weight Reduction in Down Syndrome N/A
Completed NCT01594346 - Multicenter Vitamin E Trial in Aging Persons With Down Syndrome Phase 3
Completed NCT05343468 - Life Skills Improved in Children With Down Syndrome After Using Assistive Technology N/A
Suspended NCT05755464 - Evaluation of Patients With Down Syndrome Compliance to Dental Therapy
Recruiting NCT04022460 - Using Personal Mobile Technology to Identify Obstructive Sleep Apnea in Children With Down Syndrome (UPLOAD)
Completed NCT04818437 - Effect of Core Stability Exercises and Balance Training in Postural Control Among Down Syndrome N/A